How Do MUSE Cells Work in Regenerative Medicine
Among the questions patients bring to Springs Rejuvenation, "how does this actually work?" is among the most important — and most honest. This article, reviewed by Dr. Charles Pereyra MD, walks through the scientific mechanisms that researchers believe underlie MUSE cell activity in the body.
The Starting Point: Stress Signaling
One of the properties that makes MUSE cells an area of active research interest is what scientists call autonomous homing. When tissue is damaged, inflamed, or under physiological stress, the body releases a cascade of chemical signals. Laboratory and early clinical research suggests that MUSE cells may recognize and migrate toward these signals after intravenous administration — without requiring directed injection to a specific anatomical site.
This differs meaningfully from approaches that involve placing cells directly into a target joint or tissue. If autonomous homing functions as observed in research models, it may mean that a single intravenous administration could allow cells to circulate and reach multiple areas of interest. Whether this translates to measurable clinical benefit for any individual patient is still being studied, and results may vary.
Trilineage Differentiation: What It Means
Once MUSE cells arrive at a site of stress, research suggests they may differentiate — that is, take on characteristics of the surrounding tissue. This is described as trilineage differentiation, meaning they may develop into cell types associated with three of the body's primary tissue layers:
- **Mesoderm-derived cells**: muscle, bone, cartilage, and connective tissue
- **Ectoderm-derived cells**: neural and skin tissue
- **Endoderm-derived cells**: organ linings and glandular tissue
This breadth of potential differentiation is one reason researchers consider MUSE cells distinct from standard mesenchymal stem cells (MSCs), which are typically associated with a narrower range of differentiation targets.
The Role of the SSEA-3 Marker
MUSE cells are identified in the laboratory by a surface protein called SSEA-3 (Stage-Specific Embryonic Antigen-3). This marker, more commonly associated with embryonic cells, appears on a small subpopulation of adult mesenchymal cells — roughly 1–2% of a standard MSC preparation.
The SSEA-3 marker serves as the identification tag that separates true MUSE cells from the larger MSC population. This distinction matters for quality: a preparation labeled broadly as "stem cells" may contain few or no verified MUSE cells unless the processing specifically isolates or enriches for the SSEA-3-positive fraction.
At Springs Rejuvenation, working under the direction of Dr. Charles Pereyra MD, we use authentic Dezawa-method preparations specifically developed by Professor Mari Dezawa's research group at Tohoku University — the team that first characterized this cell population.
Safety Profile in the Research Literature
A frequently discussed advantage of MUSE cells over embryonic stem cells or induced pluripotent stem cells (iPSCs) is the absence of observed tumor formation in published preclinical and clinical research to date. Embryonic and iPSC-based approaches carry documented risks of teratoma formation — uncontrolled cell growth — because of the undifferentiated nature of those starting materials.
MUSE cells, derived from adult tissue and not requiring genetic reprogramming, have not shown this pattern in published studies. That does not mean they are without any risk for any individual — it means the published evidence to date does not associate them with this particular concern. Individual patient responses vary, and results may vary.
The IV Administration Protocol
At Springs Rejuvenation, MUSE cell protocols typically involve intravenous administration. The clinical rationale aligns with the autonomous homing property described in research: allowing the cells to circulate systemically and potentially reach multiple sites. Dr. Charles Pereyra MD and the Springs clinical team evaluate each patient individually to determine whether this approach is appropriate and what monitoring is indicated.
Because these therapies are experimental, each administration is part of a medically supervised protocol with informed consent, baseline evaluation, and follow-up.
What Peer-Reviewed Research Shows (and What It Does Not)
It is important to be honest about what the science currently supports. MUSE cell research has shown promising signals across several organ systems in both preclinical models and early human studies — including work related to stroke recovery, amyotrophic lateral sclerosis, and cardiac conditions — primarily conducted in Japan.
What the research does not yet establish is a confirmed, FDA-approved therapeutic effect for any specific condition in the United States. Springs Rejuvenation presents MUSE cell therapy as an experimental option for patients who have reviewed the available evidence and wish to explore it under medical supervision. No specific outcome can be promised, and results may vary significantly from person to person.
Frequently Asked Questions
**How long does the IV procedure take?** Administration protocols vary. Your clinical consultation with the Springs team will include a detailed walkthrough of the procedure, monitoring period, and follow-up schedule.
**Can MUSE cells target a specific area of my body?** Research suggests autonomous homing toward sites of stress or damage — but targeted delivery to a specific location cannot be controlled with precision in current protocols. Individual results may vary.
**Is this the same as "stem cell therapy" I've seen advertised?** Not necessarily. Many products marketed as stem cell therapy use MSC preparations that may contain few or no verified MUSE cells. Springs Rejuvenation uses authentic Dezawa-method preparations with documented cell characterization.
**Do I need to travel internationally?** No. Springs Rejuvenation offers this protocol at our US centers under the medical direction of Dr. Charles Pereyra MD. Patients no longer need to travel to Mexico, Colombia, or overseas clinics to access authentic Dezawa-method MUSE cell science.
Our Stem Cell exosome formula is produced in an FDA approved lab, but is not an FDA approved therapy. It is currently in the experimental stages — all information provided is based on our experience with patients. Results may vary.